Replies to post #198575 on Enzolytics Inc (ENZC)

[sspalmo]

You really need to thank the author of the original post, bigtalan. It is a great summary of what happened the first several years of operation and explains the frustration of many of the long investors. Moderators can we get that post# 192959 stickied? I currently see ENZC as a gamble, especially now that Harry is in control. IF and thats a big IF,CCC (Cotropia, Chandra, Cotropia) actually had what they claimed to have had and are willing to fight for it (legal battles), then this could pay off. I am not sure if this will pay off with ENZC shares or if they will regain control of their IP and have to go public with it using a different ticker. At this point it could take some time (not days to weeks) to go through the legal process. I don't see Harry rolling over and releasing BGEN from his control without a fight. He is currently engaged in a few legal battles, some of which to me look like obvious losers (GLD vs SAGA). In my opinion CCC have a lot of work to do to regain confidence of investors because they were involved in a lot of what went wrong unless they were sleeping through it all.
Full disclosure I currently do not own any shares, I sold in November of last year. The main reason was the 11/20/23 PR stating that the GLD vs SAGA lawsuit was "frivolous". Nasdaq did not feel that the claims made by GLD were "frivolous" and decided to delist SAGA. SAGA was a SPAC and should no longer exist because of their failure to abide by their own articles of incorporation. After years of watching the daily price decline, seeing many missed deadlines/milestones (both those set internally by the company and externally by otcmarkets), and seeing fluff press releases I had enough. Why am I still here? They told a good story, and I believed that they were sincere. I thought they were just bad at running a publicly traded company. Who releases an Annual Report on Super Bowl Sunday? I may or may not buy back into ENZC, but it is going to take some real action and just some fluff PR or a post on twitter.

[docsetc]

If you run the numbers, shares, float, outstanding, cap, and the normal flow of business for any pharma that gets any 2 products successfully to market, even with average-good sales trends, and the reduce the cap to $1 billion or less, a stated goal, you'd eventually see this stock get into the $2-$4 dollar pps range. I can give you several biopharmas that started the same way and size, and are still going well today.
The one I did the best with personally, went from .08c pps, on up to $8.00 pps, volatility moves today ranging it from about $6.45 - $8.19 pps monthly. (I sold off too soon in the $4.00 range about 11 years ago.)
You're right though. Such a strategy in the trips and getting into $1.00 - $2.00 pps in a year or two is possible, and you'd be flush silly. The partner agreements they're continuing to set up now, will get you that surge to $1.00 + pps if they get it done.

GLTY